Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease

Digestive Diseases and Sciences

Volumn 56, Issue 10, 2011, Pages 2939-2946

  Chang, Matthew S ^a   Minaya, Maria T ^a   Cheng, Jianfeng ^b   Connor, Bradley A ^c   Lewis, Suzanne K ^a   Green, Peter H R ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Celiac disease; Clinical pharmacology; Diarrhea; Malabsorption; Microbiology; Small intestine; Symptom score or index

Indexed keywords

HYDROGEN; LACTULOSE; PLACEBO; RIFAXIMIN;

ADULT; ARTICLE; BACTERIAL OVERGROWTH; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL SYMPTOM RATING SCALE; GLUTEN FREE DIET; HUMAN; HYDROGEN BREATH TEST; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SMALL INTESTINE BACTERIAL OVERGROWTH; TREATMENT RESPONSE;

ADULT; BREATH TESTS; CELIAC DISEASE; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; HYDROGEN; LACTULOSE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RIFAMYCINS; TREATMENT OUTCOME;

EID: 80054757891     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1719-6     Document Type: Article

References (35)

1. P Green C Cellier 2007 Celiac disease N Engl J Med 357 1731 1743 17960014 10.1056/NEJMra071600 1:CAS:528:DC%2BD2sXht1alsLjN (Pubitemid 350005154)
2. S O'Mahony P Howdle M Losowsky 1996 Review article: management of patients with non-responsive coeliac disease Aliment Pharmacol Ther 10 671 680 8899074 10.1046/j.1365-2036.1996.66237000.x (Pubitemid 26340196)
3. H Abdallah D Leffler M Dennis C Kelly 2007 Refractory celiac disease Curr Gastroenterol Rep 9 401 405 17991341 10.1007/s11894-007-0049-5
4. KD Fine RL Meyer EL Lee 1997 The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet Gastroenterology 112 1830 1838 9178673 10.1053/gast.1997.v112.pm9178673 1:STN:280:DyaK2szit1Siuw%3D%3D (Pubitemid 27240767)
5. A Rubio-Tapia SH Barton JE Rosenblatt JA Murray 2009 Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease J Clin Gastroenterol 43 157 161 18719514 10.1097/MCG.0b013e3181557e67
6. A Tursi G Brandimarte G Giorgetti 2003 High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal Am J Gastroenterol 98 839 843 12738465 10.1111/j.1572-0241.2003.07379.x (Pubitemid 36576311)
7. SV Rana SK Sinha S Lal A Sikander K Singh 2007 Small intestinal bacterial overgrowth in North Indian patients with celiac disease Trop Gastroenterol 28 159 161 18416345 1:STN:280:DC%2BD1c3ls1ensg%3D%3D
8. AS Abdulkarim LJ Burgart J See JA Murray 2002 Etiology of nonresponsive celiac disease: results of a systematic approach Am J Gastroenterol 97 2016 2021 12190170 10.1111/j.1572-0241.2002.05917.x
9. R Prizont T Hersh MH Floch 1970 Jejunal bacterial flora in chronic small bowel disease. I. Celiac disease. II. Regional enteritis Am J Clin Nutr 23 1602 1607 4921336 1:CAS:528:DyaE3MXitFartA%3D%3D
10. E Quigley R Quera 2006 Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics Gastroenterology 130 S78 S90 16473077 10.1053/j.gastro.2005.11.046 1:CAS:528:DC%2BD28Xit12iu70%3D (Pubitemid 43208864)
11. S Rana S Bhardwaj 2008 Small intestinal bacterial overgrowth Scand J Gastroenterol 43 1030 1037 18609165 10.1080/00365520801947074 1:CAS:528:DC%2BD1cXhtVSkurrF
12. G Corazza M Menozzi A Strocchi, et al. 1990 The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing Gastroenterology 98 302 309 2295385 1:STN:280: DyaK3c7gvVGnsA%3D%3D (Pubitemid 20037910)
13. Ghoshal U, Ghoshal U, Misra A, Choudhuri G. Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol. 2004;10.
14. WM Roufail JM Ruffin 1966 Effect of antibiotic therapy on gluten-sensitive enteropathy Am J Dig Dis 11 587 593 5943764 10.1007/BF02233506 1:STN:280:DyaF287msVyltg%3D%3D
15. Pelosini I, Scarpignato C. Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract. Chemotherapy. 2005;122-130. (Pubitemid 40663199)
16. E Lauritano M Gabrielli A Lupascu, et al. 2005 Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth Aliment Pharmacol Ther 22 31 35 15963077 10.1111/j.1365-2036.2005.02516.x 1:CAS:528:DC%2BD2MXnt1ymsrw%3D (Pubitemid 40943872)
17. Scarpellini E, Gabrielli M, Lauritano E, et al. High-dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2007;25:781-786. (Pubitemid 46434913)
18. Svedlund J, Sjodin I, Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129-134. (Pubitemid 18054672)
19. AI Sharara E Aoun H Abdul-Baki R Mounzer S Sidani I Elhajj 2006 A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence Am J Gastroenterol 101 326 333 16454838 10.1111/j.1572-0241.2006.00458.x 1:CAS:528:DC%2BD28XitFSgtro%3D (Pubitemid 43381675)
20. M Pimentel EJ Chow HC Lin 2003 Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study Am J Gastroenterol 98 412 419 12591062 (Pubitemid 36232393)
21. GR Corazza A Strocchi G Gasbarrini 1987 Fasting breath hydrogen in celiac disease Gastroenterology 93 53 58 3582915 1:STN:280:DyaL2s3hvFOgtQ%3D%3D (Pubitemid 17084093)
22. M Pimentel EJ Chow HC Lin 2000 Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome Am J Gastroenterol 95 3503 3506 11151884 10.1111/j.1572-0241.2000.03368.x 1:STN:280: DC%2BD3M%2FpvFSmtA%3D%3D
23. B Walters SJ Vanner 2005 Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls Am J Gastroenterol 100 1566 1570 15984983 10.1111/j.1572-0241.2005.40795.x 1:CAS:528:DC%2BD2MXnt1ynu7Y%3D (Pubitemid 41032365)
24. M Pimentel 2009 Review of rifaximin as treatment for SIBO and IBS Expert Opin Investig Drugs 18 349 358 19243285 10.1517/13543780902780175 1:CAS:528:DC%2BD1MXitlWrtrY%3D
25. K Mustalahti S Lohiniemi P Collin N Vuolteenaho P Laippala M Mäki 2002 Gluten-free diet and quality of life in patients with screen-detected celiac disease Eff Clin Pract 5 105 113 12088289
26. S Lohiniemi M Mäki K Kaukinen P Laippala P Collin 2000 Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets Scand J Gastroenterol 35 947 949 11063154 10.1080/003655200750023002 1:STN:280:DC%2BD3crgvFyjtA%3D%3D
27. C Hallert C Granno C Grant, et al. 1998 Quality of life of adult coeliac patients treated for 10 years Scand J Gastroenterol 33 933 938 9759948 10.1080/003655298750026949 1:STN:280:DyaK1cvjtVOnug%3D%3D (Pubitemid 28439309)
28. EG Hopman HM Koopman JM Wit ML Mearin 2009 Dietary compliance and health-related quality of life in patients with coeliac disease Eur J Gastroenterol Hepatol 21 1056 1061 19209068 10.1097/MEG.0b013e3283267941
29. F Nachman H Vazquez A Gonzalez, et al. 2011 Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet Clin Gastroenterol Hepatol 9 214 219 20601132 10.1016/j.cgh.2010.06.017
30. G Midhagen C Hallert 2003 High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study Am J Gastroenterol 98 2023 2026 14499782 10.1111/j.1572-0241.2003.07632.x 1:STN:280:DC%2BD3svjvFWqsg%3D%3D (Pubitemid 37185800)
31. M Pimentel A Lembo WD Chey, et al. 2011 Rifaximin therapy for patients with irritable bowel syndrome without constipation N Engl J Med 364 22 32 21208106 10.1056/NEJMoa1004409 1:CAS:528:DC%2BC3MXisVaqsw%3D%3D
32. D Leffler M Dennis B Hyett E Kelly D Schuppan C Kelly 2007 Etiologies and predictors of diagnosis in nonresponsive celiac disease Clin Gastroenterol Hepatol 5 445 450 17382600 10.1016/j.cgh.2006.12.006 (Pubitemid 46575362)
33. SD Dorn L Hernandez MT Minaya, et al. 2010 Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center Dig Dis Sci 55 3154 3163 20668941 10.1007/s10620-010-1342-y
34. A Gasbarrini E Lauritano M Gabrielli, et al. 2007 Small intestinal bacterial overgrowth: diagnosis and treatment Dig Dis 25 237 240 17827947 10.1159/000103892 (Pubitemid 350194175)
35. R Khoshini SC Dai S Lezcano M Pimentel 2008 A systematic review of diagnostic tests for small intestinal bacterial overgrowth Dig Dis Sci 53 1443 1454 17990113 10.1007/s10620-007-0065-1